BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 4,760.00
-5.00 (-0.10%)
At close: Sep 11, 2026
BioNote Market Cap
BioNote has a market cap or net worth of 480.35 billion as of September 11, 2026. Its market cap has decreased by -21.80% in one year.
Market Cap
480.35B
Enterprise Value
115.28B
Revenue
126.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,760.00
ChartMarket Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 480.35B, a decrease of -55.73%. That is a compound annual growth rate of -19.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 480.35B | -13.36% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SEERS | 886.79B |
| InBody Co.,Ltd | 778.11B |
| SD Biosensor | 729.68B |
| i-SENS | 477.64B |
| T&L Co., Ltd. | 449.59B |
| WON TECH | 428.80B |
| DRTECH | 420.72B |
| Samyang Biopharm | 370.31B |